226 related articles for article (PubMed ID: 32152647)
1. Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus.
Singh SS; Rashid M; Lieverse AG; Kronenberg F; Lamina C; Mulder MT; de Rijke YB; Sijbrands EJG; van Hoek M
Diabetologia; 2020 Jun; 63(6):1248-1257. PubMed ID: 32152647
[TBL] [Abstract][Full Text] [Related]
2. Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia.
Page MM; Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
Clin Chim Acta; 2020 Nov; 510():211-215. PubMed ID: 32681934
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.
Qi Q; Workalemahu T; Zhang C; Hu FB; Qi L
Eur Heart J; 2012 Feb; 33(3):325-34. PubMed ID: 21900290
[TBL] [Abstract][Full Text] [Related]
4. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
[TBL] [Abstract][Full Text] [Related]
5. Investigation of LPA sequence variants rs6415084, rs3798220 with conventional coronary artery disease in Iranian CAD patients.
Rouhani B; Ghaderian SMH; Salehi Z
Hum Antibodies; 2019; 27(2):99-104. PubMed ID: 30594920
[TBL] [Abstract][Full Text] [Related]
6. LPA Gene, Ethnicity, and Cardiovascular Events.
Lee SR; Prasad A; Choi YS; Xing C; Clopton P; Witztum JL; Tsimikas S
Circulation; 2017 Jan; 135(3):251-263. PubMed ID: 27831500
[TBL] [Abstract][Full Text] [Related]
7. Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease.
Anderson JL; Knight S; May HT; Horne BD; Bair TL; Huntinghouse JA; Rollo JS; Muhlestein JB; Carlquist JF
Am J Cardiol; 2013 Sep; 112(6):799-804. PubMed ID: 23735648
[TBL] [Abstract][Full Text] [Related]
8. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.
Lu W; Cheng YC; Chen K; Wang H; Gerhard GS; Still CD; Chu X; Yang R; Parihar A; O'Connell JR; Pollin TI; Angles-Cano E; Quon MJ; Mitchell BD; Shuldiner AR; Fu M
Hum Mol Genet; 2015 Apr; 24(8):2390-400. PubMed ID: 25575512
[TBL] [Abstract][Full Text] [Related]
9. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
J Am Coll Cardiol; 2014 Feb; 63(5):470-7. PubMed ID: 24161338
[TBL] [Abstract][Full Text] [Related]
10. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
Zewinger S; Kleber ME; Tragante V; McCubrey RO; Schmidt AF; Direk K; Laufs U; Werner C; Koenig W; Rothenbacher D; Mons U; Breitling LP; Brenner H; Jennings RT; Petrakis I; Triem S; Klug M; Filips A; Blankenberg S; Waldeyer C; Sinning C; Schnabel RB; Lackner KJ; Vlachopoulou E; Nygård O; Svingen GFT; Pedersen ER; Tell GS; Sinisalo J; Nieminen MS; Laaksonen R; Trompet S; Smit RAJ; Sattar N; Jukema JW; Groesdonk HV; Delgado G; Stojakovic T; Pilbrow AP; Cameron VA; Richards AM; Doughty RN; Gong Y; Cooper-DeHoff R; Johnson J; Scholz M; Beutner F; Thiery J; Smith JG; Vilmundarson RO; McPherson R; Stewart AFR; Cresci S; Lenzini PA; Spertus JA; Olivieri O; Girelli D; Martinelli NI; Leiherer A; Saely CH; Drexel H; Mündlein A; Braund PS; Nelson CP; Samani NJ; Kofink D; Hoefer IE; Pasterkamp G; Quyyumi AA; Ko YA; Hartiala JA; Allayee H; Tang WHW; Hazen SL; Eriksson N; Held C; Hagström E; Wallentin L; Åkerblom A; Siegbahn A; Karp I; Labos C; Pilote L; Engert JC; Brophy JM; Thanassoulis G; Bogaty P; Szczeklik W; Kaczor M; Sanak M; Virani SS; Ballantyne CM; Lee VV; Boerwinkle E; Holmes MV; Horne BD; Hingorani A; Asselbergs FW; Patel RS; ; Krämer BK; Scharnagl H; Fliser D; März W; Speer T
Lancet Diabetes Endocrinol; 2017 Jul; 5(7):534-543. PubMed ID: 28566218
[TBL] [Abstract][Full Text] [Related]
11. LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography.
Santos PC; Bueno CT; Lemos PA; Krieger JE; Pereira AC
Lipids Health Dis; 2014 Apr; 13():74. PubMed ID: 24776095
[TBL] [Abstract][Full Text] [Related]
12. Association of LPA Variants With Aortic Stenosis: A Large-Scale Study Using Diagnostic and Procedural Codes From Electronic Health Records.
Chen HY; Dufresne L; Burr H; Ambikkumar A; Yasui N; Luk K; Ranatunga DK; Whitmer RA; Lathrop M; Engert JC; Thanassoulis G
JAMA Cardiol; 2018 Jan; 3(1):18-23. PubMed ID: 29128868
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention.
Li ZG; Li G; Zhou YL; Chen ZJ; Yang JQ; Zhang Y; Sun S; Zhong SL
Lipids Health Dis; 2013 Aug; 12():127. PubMed ID: 23978127
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
Clarke R; Peden JF; Hopewell JC; Kyriakou T; Goel A; Heath SC; Parish S; Barlera S; Franzosi MG; Rust S; Bennett D; Silveira A; Malarstig A; Green FR; Lathrop M; Gigante B; Leander K; de Faire U; Seedorf U; Hamsten A; Collins R; Watkins H; Farrall M;
N Engl J Med; 2009 Dec; 361(26):2518-28. PubMed ID: 20032323
[TBL] [Abstract][Full Text] [Related]
15. The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?
Ye Z; Haycock PC; Gurdasani D; Pomilla C; Boekholdt SM; Tsimikas S; Khaw KT; Wareham NJ; Sandhu MS; Forouhi NG
Diabetes; 2014 Jan; 63(1):332-342. PubMed ID: 24089516
[TBL] [Abstract][Full Text] [Related]
16. Association between lipoprotein(a) level and type 2 diabetes: no evidence for a causal role of lipoprotein(a) and insulin.
Buchmann N; Scholz M; Lill CM; Burkhardt R; Eckardt R; Norman K; Loeffler M; Bertram L; Thiery J; Steinhagen-Thiessen E; Demuth I
Acta Diabetol; 2017 Nov; 54(11):1031-1038. PubMed ID: 28866807
[TBL] [Abstract][Full Text] [Related]
17. Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study.
Singh SS; Roeters-van Lennep JE; Lemmers RFH; van Herpt TTW; Lieverse AG; Sijbrands EJG; van Hoek M
Acta Diabetol; 2020 Jun; 57(6):725-732. PubMed ID: 32025877
[TBL] [Abstract][Full Text] [Related]
18. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
[TBL] [Abstract][Full Text] [Related]
19. Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study.
Perrot N; Verbeek R; Sandhu M; Boekholdt SM; Hovingh GK; Wareham NJ; Khaw KT; Arsenault BJ
Atherosclerosis; 2017 Jan; 256():47-52. PubMed ID: 27998826
[TBL] [Abstract][Full Text] [Related]
20. Low "quotient" Lp(a) concentration mediates autoimmune activation and independently predicts cardiometabolic risk.
Onat A; Çoban N; Can G; Yüksel M; Karagöz A; Yüksel H; Ademoğlu E; Erginel-Ünaltuna N
Exp Clin Endocrinol Diabetes; 2015 Jan; 123(1):11-8. PubMed ID: 25314652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]